Literature DB >> 34072295

Trypsin-Like Proteases and Their Role in Muco-Obstructive Lung Diseases.

Emma L Carroll1, Mariarca Bailo2, James A Reihill1, Anne Crilly2, John C Lockhart2, Gary J Litherland2, Fionnuala T Lundy3, Lorcan P McGarvey3, Mark A Hollywood4, S Lorraine Martin1.   

Abstract

Trypsin-like proteases (TLPs) belong to a family of serine enzymes with primary substrate specificities for the basic residues, lysine and arginine, in the P1 position. Whilst initially perceived as soluble enzymes that are extracellularly secreted, a number of novel TLPs that are anchored in the cell membrane have since been discovered. Muco-obstructive lung diseases (MucOLDs) are characterised by the accumulation of hyper-concentrated mucus in the small airways, leading to persistent inflammation, infection and dysregulated protease activity. Although neutrophilic serine proteases, particularly neutrophil elastase, have been implicated in the propagation of inflammation and local tissue destruction, it is likely that the serine TLPs also contribute to various disease-relevant processes given the roles that a number of these enzymes play in the activation of both the epithelial sodium channel (ENaC) and protease-activated receptor 2 (PAR2). More recently, significant attention has focused on the activation of viruses such as SARS-CoV-2 by host TLPs. The purpose of this review was to highlight key TLPs linked to the activation of ENaC and PAR2 and their association with airway dehydration and inflammatory signalling pathways, respectively. The role of TLPs in viral infectivity will also be discussed in the context of the inhibition of TLP activities and the potential of these proteases as therapeutic targets.

Entities:  

Keywords:  COVID-19; ENaC; PAR2; SARS-CoV-2; airway dehydration; inflammation; influenza; protease inhibitors; serpins; trypsin-like proteases; virus activation

Mesh:

Substances:

Year:  2021        PMID: 34072295     DOI: 10.3390/ijms22115817

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  3 in total

1.  Myeloid Protease-Activated Receptor-2 Contributes to Influenza A Virus Pathology in Mice.

Authors:  Randall C Gunther; Vanthana Bharathi; Stephen D Miles; Lauryn R Tumey; Clare M Schmedes; Kohei Tatsumi; Meagan D Bridges; David Martinez; Stephanie A Montgomery; Melinda A Beck; Eric Camerer; Nigel Mackman; Silvio Antoniak
Journal:  Front Immunol       Date:  2021-12-01       Impact factor: 7.561

2.  Trypsin enhances SARS-CoV-2 infection by facilitating viral entry.

Authors:  Yeeun Kim; Guehwan Jang; Duri Lee; Nara Kim; Jeong Won Seon; Young-Hoan Kim; Changhee Lee
Journal:  Arch Virol       Date:  2022-01-26       Impact factor: 2.685

3.  Novel Inhibitors and Activity-Based Probes Targeting Trypsin-Like Serine Proteases.

Authors:  Timothy E G Ferguson; James A Reihill; S Lorraine Martin; Brian Walker
Journal:  Front Chem       Date:  2022-04-21       Impact factor: 5.545

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.